,,iv  #aah? ,,congress  #b;d ,session   
,h4 ,,res4 #adba  ,,9 ,,! ,,h\se ,,(    
,,repres5tatives  ,septemb] #c1         
#bjbd,mr4 ,fong 7= himself1 ,mr4 ,mull91
 ,ms4 ,b>ragn1 & ,mr4 ,co/a7 submitt$ ! 
foll[+ resolution2 :i* 0 ref]r$ to !    
,committee on ,en]gy & ,comm]ce         
,,resolution  ,support+ ! goals ( ,blood
 ,canc] ,aw>5ess ,mon?4  ,:]eas blood   
canc] includes leukemia1 lymphoma1      
myeloma1 myelodyspla/ic syndromes1 &    
myeloprolif]ative neoplasms2 ,:]eas     
blood canc] curr5tly afflicts m ?an     
#a1fjj1jjj p 9 ! ,unit$ ,/ates1 ) a     
p]son be+ diagnos$ e #c m9utes2 ,:]eas  
blood canc] is project$ to cause ! dea?s
 ( m ?an #eg1cjj p 9 ! ,unit$ ,/ates ?is
 ye>2 ,:]eas /eady support = blood canc]
 rese>* has produc$ break?r\gh treatm5t 
advances2 ,:]eas blood canc] rese>* has 
produc$ promis+ results = treatm5ts l   
immuno!rapy1 t>get$ !rapy1 & m9imal     
residual disease te/+1 among o!rs2      
,:]eas ,congress has provid$ /rong      
support = blood canc] rese>* t has      

contribut$ to important treatm5t        
advances & yield$ significant           
improvem5ts 9 pati5t survival2 ,:]eas   
,congress mu/ cont9ue to support blood  
canc] rese>* to improve ! e>ly diagnosis
 & effective treatm5t ( blood canc]2    
,:]eas ,septemb] is ,blood ,canc]       
,aw>5ess ,mon?2 & ,:]eas ,blood ,canc]  
,aw>5ess ,mon? is a "t to-- 7#a7 assess 
! *all5ges & opportunities ( blood canc]
 rese>*2  7#b7 support ef=ts to increase
 aw>5ess (1 & education ab\t1 blood     
canc]2 &  7#c7 recognize ! ne$ =        
additional rese>* into e>ly diagnosis1  
scre5+1 & treatm5t = blood canc]3 ,n[1  
!re=e1 be x  ,t ! ,h\se (               
,repres5tatives-- 7#a7 supports ! goals 
( ,blood ,canc] ,aw>5ess ,mon?2 &  7#b7 
enc\rages p 9 ! ,unit$ ,/ates to-- 7,a7 
educate !mselves ab\t blood canc]2  7,b7
 advocate = blood canc] rese>*1         
education1 & c>e2 &  7,c7 (f] support to
 individuals liv+ ) blood canc] & _!    
families4